Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Trevi Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 164
- +11 vs. Q2 2025
- Shares held
- 129.3M
- +14.7M (+12.8%) vs. Q2 2025
- Total value
- $1.18B
- +$556.1M (+88.7%) vs. Q2 2025
- New holders
- 35
- 65 more added
- Sold out
- 24
- 42 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 100,000 | $915.0K | 0.33% | −200,000−66.7% | Reduced |
| LMR Partners LLP | 100,000 | $915.0K | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 100,282 | $917.6K | 0.00% | −3,946,153−97.5% | Reduced |
| Citadel Advisors LLC | 102,534 | $938.2K | 0.00% | −1,216,732−92.2% | Reduced |
| Sectoral Asset Management Inc | 105,950 | $969.4K | 0.60% | −28,200−21.0% | Reduced |
| Rhumbline Advisers | 115,022 | $1.05M | 0.00% | +8,620+8.1% | Added |
| UBS Asset Management Americas Inc | 116,477 | $1.07M | 0.00% | +116,477 | New |
| Two Sigma Investments, LP | 119,930 | $1.10M | 0.00% | −310−0.3% | Reduced |
| State of Wisconsin Investment Board | 123,276 | $1.13M | 0.00% | +6,031+5.1% | Added |
| Swiss National Bank | 161,700 | $1.48M | 0.00% | +161,700 | New |
| Royal Bank of Canada | 168,994 | $1.55M | 0.00% | −655,186−79.5% | Reduced |
| Nuveen, LLC | 183,329 | $1.68M | 0.00% | +13,870+8.2% | Added |
| Fred Alger Management, LLC | 191,045 | $1.75M | 0.01% | +131,620+221.5% | Added |
| Velan Capital Investment Management LP | 205,000 | $1.88M | 1.76% | +205,000 | New |
| Barclays PLC | 216,885 | $1.98M | 0.00% | −298,591−57.9% | Reduced |
| Bank of New York Mellon Corp | 226,339 | $2.07M | 0.00% | +60,074+36.1% | Added |
| Renaissance Technologies LLC | 293,300 | $2.68M | 0.00% | −196,000−40.1% | Reduced |
| UBS Group AG | 298,612 | $2.73M | 0.00% | −55,613−15.7% | Reduced |
| StemPoint Capital LP | 350,710 | $3.21M | 0.65% | +350,710 | New |
| Opaleye Management Inc. | 390,000 | $3.57M | 0.50% | 00.0% | Unchanged |
| Invesco Ltd. | 483,070 | $4.42M | 0.00% | +160,731+49.9% | Added |
| Burkehill Global Management, LP | 525,000 | $4.80M | 0.27% | 00.0% | Unchanged |
| EAM Investors, LLC | 549,479 | $4.97M | 0.57% | +62,855+12.9% | Added |
| Panagora Asset Management Inc | 570,468 | $5.22M | 0.02% | +766+0.1% | Added |
| Silverarc Capital Management, LLC | 588,789 | $5.39M | 0.78% | +49,202+9.1% | Added |
| Prudential Financial Inc | 602,654 | $5.51M | 0.01% | +376,273+166.2% | Added |
| Peregrine Capital Management LLC | 620,464 | $5.68M | 0.17% | +620,464 | New |
| Balyasny Asset Management LLC | 626,462 | $5.73M | 0.01% | −1,727,940−73.4% | Reduced |
| Sphera Funds Management Ltd. | 643,957 | $5.89M | 1.40% | −156,000−19.5% | Reduced |
| Qube Research & Technologies Ltd | 651,679 | $5.96M | 0.01% | +203,827+45.5% | Added |
| Millennium Management LLC | 727,596 | $6.66M | 0.01% | +570,352+362.7% | Added |
| Northern Trust Corp | 736,930 | $6.74M | 0.00% | +160,459+27.8% | Added |
| Goldman Sachs Group Inc | 787,454 | $7.21M | 0.00% | +488,409+163.3% | Added |
| J. Goldman & Co LP | 792,806 | $7.25M | 0.27% | −186,292−19.0% | Reduced |
| Charles Schwab Investment Management Inc | 806,331 | $7.38M | 0.00% | +580,396+256.9% | Added |
| Point72 Asset Management, L.P. | 941,929 | $8.62M | 0.02% | −786,747−45.5% | Reduced |
| Flputnam Investment Management Co | 1,048,102 | $9.59M | 0.14% | +961,150+1,105.4% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,256,782 | $11.5M | 6.65% | +110,672+9.7% | Added |
| Eventide Asset Management, LLC | 1,381,324 | $12.6M | 0.21% | 00.0% | Unchanged |
| Raymond James Financial Inc | 1,411,037 | $12.9M | 0.00% | +334,354+31.1% | Added |
| Susquehanna International Group, LLP | 1,600,742 | $14.6M | 0.02% | +1,473,157+1,154.6% | Added |
| Bank of America Corp | 1,836,839 | $16.8M | 0.00% | +739,342+67.4% | Added |
| Artia Global Partners LP | 1,999,702 | $18.3M | 3.22% | +687,862+52.4% | Added |
| Acorn Capital Advisors, LLC | 2,144,844 | $19.6M | 9.96% | 00.0% | Unchanged |
| Logos Global Management LP | 2,200,000 | $20.1M | 1.99% | +1,350,000+158.8% | Added |
| State Street Corp | 2,219,422 | $20.3M | 0.00% | +386,502+21.1% | Added |
| Geode Capital Management, LLC | 2,220,926 | $20.3M | 0.00% | +434,081+24.3% | Added |
| Siren, L.L.C. | 2,536,867 | $23.2M | 0.91% | −1,401,926−35.6% | Reduced |
| Affinity Asset Advisors, LLC | 2,800,000 | $25.6M | 2.38% | +265,942+10.5% | Added |
| Octagon Capital Advisors LP | 2,815,000 | $25.8M | 4.02% | −857,000−23.3% | Reduced |
| Wellington Management Group LLP | 3,253,888 | $29.8M | 0.01% | +3,081,906+1,792.0% | Added |
| FMR LLC | 3,299,891 | $30.2M | 0.00% | +2,931,362+795.4% | Added |
| OrbiMed Advisors LLC | 3,308,400 | $30.3M | 0.73% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 3,406,955 | $31.2M | 5.10% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 4,292,451 | $39.3M | 0.01% | +11,096+0.3% | Added |
| Morgan Stanley | 4,301,726 | $39.4M | 0.00% | +3,277,715+320.1% | Added |
| Marshall Wace, LLP | 4,841,751 | $44.3M | 0.05% | +2,363,835+95.4% | Added |
| Vivo Capital, LLC | 5,094,668 | $46.6M | 3.75% | +606,765+13.5% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 5,128,875 | $46.9M | 0.12% | +3,585,875+232.4% | Added |
| Vanguard Group Inc | 5,826,986 | $53.3M | 0.00% | +510,295+9.6% | Added |
| Rubric Capital Management LP | 8,531,860 | $78.1M | 1.05% | 00.0% | Unchanged |
| BlackRock, Inc. | 9,901,053 | $90.6M | 0.00% | +1,696,047+20.7% | Added |
| Frazier Life Sciences Management, L.P. | 10,259,409 | $93.9M | 2.81% | 00.0% | Unchanged |
| NEA Management Company, LLC | 13,222,228 | $121.0M | 6.64% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −493,735−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −154,854−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −86,830−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −74,300−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −64,589−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −54,957−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −44,981−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −33,962−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −25,848−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,149−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −16,379−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −12,644−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |
| Longaeva Partners L.P. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,689−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −461−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| First Horizon Advisors, Inc. | – | – | – | – | Not filed |